Instituto Rosenbusch S.A. (BCBA:ROSE)

Argentina flag Argentina · Delayed Price · Currency is ARS
162.00
-4.00 (-2.41%)
Last updated: Apr 28, 2026, 2:13 PM BRT
80.00%
Market Cap 7.07B
Revenue (ttm) 6.40B
Net Income (ttm) -4.60B
Shares Out 42.59M
EPS (ttm) -107.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 120,955
Open 164.00
Previous Close 166.00
Day's Range 162.00 - 164.00
52-Week Range 83.50 - 450.00
Beta 0.04
RSI 46.25
Earnings Date Apr 1, 2026

About Instituto Rosenbusch

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, i... [Read more]

Sector Healthcare
Founded 1917
Country Argentina
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol ROSE
Full Company Profile

Financial Performance

In 2025, Instituto Rosenbusch's revenue was 6.40 billion, a decrease of -41.17% compared to the previous year's 10.89 billion. Losses were -4.60 billion, 146.6% more than in 2024.

Financial Statements

News

There is no news available yet.